Anti-Chol-1 Antigen, GQ1bα, Antibodies Are Associated with Alzheimer’s Disease

Myelin glycosphingolipid immunoreactivity and CSF levels in multiple sclerosis

(2011) S. Haghighi et al.   ACTA NEUROLOGICA SCANDINAVICA

Different antiganglioside antibody pattern between relapsing-remitting and progressive multiple sclerosis

(2010) N. Acarín et al.   ACTA NEUROLOGICA SCANDINAVICA

Ganglioside Metabolism in a Transgenic Mouse Model of Alzheimer's Disease: Expression of Chol-1α Antigens in the Brain

(2010) Toshio Ariga et al.   ASN Neuro

Establishment of a new conditionally immortalized human brain microvascular endothelial cell line retaining an in vivo blood-brain barrier function

(2010) Yasuteru Sano et al.   JOURNAL OF CELLULAR PHYSIOLOGY

Role of proteoglycans and glycosaminoglycans in the pathogenesis of Alzheimer's disease and related disorders: Amyloidogenesis and therapeutic strategies-A review

(2010) Toshio Ariga et al.   JOURNAL OF NEUROSCIENCE RESEARCH

Anti-carbohydrate antibodies of normal sera: Findings, surprises and challenges

(2009) Margaret E. Huflejt et al.   MOLECULAR IMMUNOLOGY

Antibodies Against GM1 in Demented Patients

(2008) Eleni Hatzifilippou et al.   American Journal of Alzheimers Disease and Other Dementias

Thematic Review Series: Sphingolipids.Role of ganglioside metabolism in the pathogenesis of Alzheimer's disease—a review,

(2008) Toshio Ariga et al.   JOURNAL OF LIPID RESEARCH

Caffeine blocks disruption of blood brain barrier in a rabbit model of Alzheimer's disease

(2008) Xuesong Chen et al.   Journal of Neuroinflammation

Autoantibodies and neurodegeneration in multiple sclerosis

(2008) Tamara Vyshkina et al.   LABORATORY INVESTIGATION